https://gusacitinibinhibitor.c....om/throughout-vivo-d
V.Although the use of person embryonic stem cells (hESCs) in stem cell-replacement therapy remains promising, its potential is hindered by a decreased mobile success price in post-transplantation inside the internal ear. Here, we aim to improve the in vitro as well as in vivo survival price and neuronal differentiation of otic neuronal progenitors (ONPs) by creating an artificial stem mobile niche composed of three-dimensional (3D) hESC-derived ONP spheroid
Like
Comment
Share
